Abstract
On the basis of the multitude of studies performed over the last 20 years, many recommendations could be made concerning optimizing the yield and reliability of information from the exercise test for patients with angina. Many of these suggestions, however, have escaped application to clinical pharmaceutical trials. The strength of conclusions made in regard to drug efficacy are only as valuable as the quality of the performance of the exercise test. The following are recommendations for optimizing exercise testing when studying pharmacological therapy for patients with angina:
-
1.
Only patients who exhibit a stable, reproducible chest pain response to exercise are appropriate for such studies. Several preliminary tests are required to determine the appropriateness of a given patient, and a 10% reproducibility criteria should be used.
-
2.
Chest pain should be graded carefully throughout the test, and analysis points should include the onset of pain, the occurrence of moderate pain, and peak angina. The testing endpoint should reflect the intensity of pain that would cause the patient to stop normal daily activities and/or take a sublingual nitroglycerin pill.
-
3.
Exercise protocols should be individualized considering the subject tested and the purpose of the test; ideally the onset of angina should occur within 3–6 minutes and peak angina should be achieved within a duration of 8–12 minutes. Increments in work should be ≤ MET.
-
4.
Gas exchange techniques greatly enhance the precision and reproducibility for quantifying work. Their use in multicenter trials of drug efficacy should be strongly encouraged.
-
5.
The angina response to exercise can be greatly affected by the laboratory environment and other factors, including temperature, time of day, smoking, and meals. Exercise testing should be performed in a well-ventilated room and at a temperature of 20–22°C. Serial testing should be performed at the same time of day and at least 3 hours after abstaining from food, caffeinated beverages, and smoking.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Webster MWI, Sharpe DN. Exercise testing in angina pectoris: The importance of protocol design in clinical trials. Am Heart J 1989;117:505–508.
Myers J, Buchanan N, Walsh D, Kraemer M, McAuley P, Hamilton-Wessler M, Froelicher VF. Comparison of the ramp versus standard exercise protocols. J Am Coll Cardiol 1991;17:1334–1342.
Buchfuhrer MJ, Hansen JE, Robinson TE, Sue DY, Wasserman K, Whipp BJ. Optimizing the exercise protocol for cardiopulmonary assessment. J Appl Physiol 1983;55:1558–1564.
Panza JA, Quyyumi AA, Diodati JG, Callaham TS, Epstein SE. Prediction of the frequency and duration of ambulatory myocardial ischemia in patients with stable coronary artery disease by determination of the ischemic threshold from exercise testing: Importance of the exercise protocol. J Am Coll Cardiol 1991;17:657–663.
Lipkin DP, Canepa-Anson R, Stephens MR, Poole-Wilson PA. Factors determining symptoms in heart failure: Comparison of fast and slow exercise tests. Br Heart J 1986;55:439–445.
Garber CE, Carleton RA, Camaione DN, Heller GV. The threshold for myocardial ischemia varies in patients with coronary artery disease depending on the exercise protocol. J Am Coll Cardiol 1991;17:1256–1262.
Myers J, Buchanan N, Smith D, Neutel J, Bowes E, Walsh D, Froelicher VF. Individualized ramp treadmill: Observations on a new protocol. Chest 1992;101:2305–2415.
Myers J. Perception of chest pain during exercise in patients with coronary artery disease. Med Sci Sports Exer, 1994, Sept.
Cox J, Naylor CD. The Canadian Cardiovascular Society grading scale for angina pectoris: Is it time for refinements? Ann Intern Med 1992;117:677–683.
Neuberg GW, Friedman SH, Weiss MB, Herman MV. Cardiopulmonary exercise testing. The clinical value of gas exchange data. Arch Intern Med 1988;148:2221–2226.
Wasserman K. New concepts in assessing cardiovascular function. Circulation 1988;78:1060–1071.
Myers J, Froelicher VF. Optimizing the exercise test for pharmacological investigations. Circulation 1990;82:1839–1846
Stachenfeld NS, Eskenazi M, Gleim GW, Coplan NL, Nicholas JA. Predictive accuracy of criteria used to assess maximal oxygen consumption. Am Heart J 1992;123:922.
Coplan NL, Gleim GW, Stachenfeld N, Eskenazi M, et al. Evaluation of 85% predicted maximal heart rate as an endpoint for diagnostic testing. Am Heart J 1991;122:1790–1791.
Bobbio M, Detrano R. A lesson from the controversy about heart rate adjustment of ST segment depression. Circulation 1991;84:1410–1413.
Okin PM, Bergman G, Kligfield P. Effect of ST segment measurement point on performance of standard and heart rate-adjusted ST segment criteria for the identification of coronary artery disease. Circulation 1991;84:57–66.
Kligfield P, Ameisen O, Okin PM. Heart rate adjustment of ST segment depression for improved detection of coronary artery disease. Circulation 1989;79:245–255.
Hollenberg M, Budge WR, Wisneski JA, Gertz EW. Treadmill score quantifies electrocardiographic response to exercise and improves test accuracy and reproducibility. Circulation 1980;61:276.
Lachterman B, Lehmann KG, Detrano R, Neutel J, Froelicher VF. Comparison of ST segment/heart rate index to standard ST criteria for analysis of exercise electrocardiogram. Circulation 1990;82:44–50.
Mark DB, Shaw L, Harreil FE, Hlatky MA, Lee KL, Bengtson JR, McCants CB, Califf RM, Pryor DB. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med 1991;325:849–853.
Lam J, Chaitman BR. Exercise lead systems and newer electrocardiographic parameters. J Cardiac Rehabil 1984;4:507–516.
Lachterman B, Lehmann KG, Abrahamson D, Froelicher VF. “Recovery only” ST segment depression and the predictive accuracy of the exercise test. Ann Intern Med 1990;112:11–16.
Ribisl, PM, Liu J, Mousal, Herbert WG, Miranda CP, Froning JN, Froelicher VF. Comparison of computer ST criteria for diagnosis of severe coronary artery disease. Am J Cardiol, 1993, in press.
Juneau M, Johnstone M, Dempsey E, Waters DD. Exercise-induced myocardial ischemia in a cold environment: Effect of anti-anginal medications. Circulation 1989;79:1015–1020.
Lassvik CT, Areskog N. Angina in cold environment: Reactions to exercise. Br Heart J 1979;42:396–401.
Shea MJ, Deanfield JE, de Landsheere CM, Wilson RA, Kensett M, Selwyn AP. Asymptomatic ischemia following cold provocation. Am Heart J 1987;114:469–476.
Philbrick JT, Horwitz RI, Feinstein AR. Methodologic problems of exercise testing for coronary artery disease: Groups, analysis and bias. Am J Cardiol 1980;46:807–812.
Philbrick JT, Horwitz RI, Feinstein AR, Langou RA, Chandler JP. The limited spectrum of patients studied in exercise test research. Analyzing the tip of the iceberg. JAMA 1982;248:2467–2470.
Redwood DR, Rosing DR, Goldstein RE, Beiser GD, Epstein SE. Importance of the design of an exercise protocol in the evaluation of patients with angina pectoris. Circulation 1971;43:618–628.
Starling MR, Moody M, Crawford MH, Levi B, O’Rourke RA. Repeat treadmill exercise testing: Variability of results in patients with angina pectoris. Am Heart J 1984;107:298–303.
Sullivan M, Genfer F, Savvides M, Roberts M, Myers J, Froelicher VF. The reproducibility of hemodynamic electrocardiographic, and gas exchange data during treadmill exercise in patients with stable angina pectoris. Chest 1984;86:375–382.
Pinsky DJ, Ahern D, Wilson PB, Kukin ML, Packer M. How many exercise tests are needed to minimize the placebo effect of serial exercise testing in patients with chronic heart failure? Circulation 1989;80(Suppl II):II426.
Kraemer MD, Sullivan M, Atwood JE, Forbes S, Myers J, Froelicher VF. Reproducibility of treadmill exercise data in patients with atrial fibrillation. Cardiology 1989;76:234–242.
Elborn JS, Stanford CF, Nichols DP. Reproducibility of cardiopulmonary parameters during exercise in patients with chronic cardiac failure: The need for a preliminary test. Eur Heart J 1990;11:75–81.
Garrard CS, Emmons C. The reproducibility of the respiratory responses to maximum exercise. Respiration 1986;49:94–100.
Joy M, Pollard CM. Diurnal variation in exercise responses in angina pectoris. Br Heart J 1982;48:156–160.
Miranda CP, Liu J, Kadar A, Janosi A, Froning J, Lehmann KG, Froelicher VF. Usefulness of exercise-induced ST-segment depression in the inferior leads during exercise testing as a marker for coronary artery disease. Am J Cardiol 1992;69:303–307.
Borg G, Holmgren A, Lindbland I. Quantitative evaluation of chest pain. Acta Med Scand 1981;644:43–45.
Borg G, Holmgren A, Lindbland I. Perception of chest pain during physical work in a group of patients with angina pectoris. Stockholm, Sweden: Reports from the Institute of Applied Psychology 1980;81:1–8.
American College of Sports Medicine. Guidelines for Exercise Testing and Exercise Prescription. Philadelphia: Lea & Febiger, 1991.
Campeau. Grading of angina pectoris. Circulation 1976;54:522–523.
New York Heart Association Criteria Committee— Koosman CE, Chairman. Diseases of the Heart and Blood Vessels: Nomenclature and Criteria for Diagnosis, 6th ed. Boston: Little, Brown, 1964:112.
American Heart Association Council of Cardiovascular Surgery Coronary Artery Disease Reporting System. Circulation 1975;51:22.
Redwood DR, Rosing DR, Epstein SE. Circulatory and symptomatic effects of physical training in patients with coronary-artery disease and angina pectoris. N Engl J Med 1972;286:959–965.
Sullivan M, Myers J, Buchanan N, Froelicher VF. Effect of sublingual nitroglycerin on the gas exchange response to exercise in patients with angina pectoris. Am J Cardiol, 1993;72:767–769.
Stuart RJ, Ellestad MH. National survey of exercise stress testing facilities. Chest 1980;77:94–97.
Haskell W, Savin W, Oldridge N, DeBusk R. Factors influencing estimated oxygen uptake during exercise testing soon after myocardial infarction. Am J Cardiol 1982;50:299–304.
Sullivan M, McKirnan MD. Errors in predicting functional capacity for postmyocardial infarction patients using a modified Bruce protocol. Am Heart J 1984;107:486–491.
Fletcher GF, Froelicher VF, Hartley LH, Haskell WL, Pollock ML. Exercise standards: A statement for health professionals from the American Heart Association. Circulation 1990;82:2286–2322.
Smokier PE, MacAlpin RN, Alvaro A, Kattus AA. Reproducibility of a multi-stage near maximal treadmill test for exercise tolerance in angina pectoris. Circulation 1973;48:346–351.
Hambrecht R, Schuler G, Muth T, Grunze MF, Marburger CT, Niebauer J, Methfessel SM, Kubler W. Greater diagnostic sensitivity of treadmill versus cycle exercise testing of asymptomatic men with coronary artery disease. Am J Cardiol 1992;70:141–146.
Wicks JR, Sutton JR, Oldridge NB, Jones NL. Comparison of the electrocardiographic changes induced by maximum exercise testing with treadmill and cycle ergometer. Circulation 1978;57:1066–1069.
Roberts JM, Sullivan M, Froelicher VF, Genter F, Myers J. Predicting oxygen uptake from treadmill testing in normal subjects and coronary artery disease patients. Am Heart J 1984;108:1454–1460.
Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J 1973;85:546–562.
Froelicher VF, Thompson AJ, Noguera L, Davis G, Stewart AJ, Triebwasser JH. Prediction of maximal oxygen consumption. Comparison of the Bruce and Balke treadmill protocols. Chest 1975;68:331–336.
Myers J, Salleh A, Buchanan N, Smith D, Neutel J, Bowes E, Froelicher VF. Ventilatory mechanisms of exercise intolerance in chronic heart failure. Am Heart J 1992;124:710–719.
Sullivan MJ, Higginbotham MB, Cobb FR. Increased exercise ventilation in patients with chronic heart failure: Intact ventilatory control despite hemodynamic and pulmonary abnormalities. Circulation 1988;77:552–559.
Hughson RL. Alterations in the oxygen deficit-oxygen debt relationships with beta-adrenergic receptor blockade in man. J Physiol (Lond) 1984;349:375–387.
Petersen ES, Whipp BJ, Davis JA, Huntsman DJ, Brown HV, Wasserman K. Effects of β-adrenergic blockade on ventilation and gas exchange during exercise in humans. J Appl Physiol 1983;54:1306–1313.
Twentyman OP, Disley A, Gribbin HR, Alberti KGM, Tattersfield AE. Effect of β-adrenergic blockade on respiratory and metablic responses to exercise. J Appl Physiol 1981;51:788–792.
Linnarsson D. Dynamics of pulmonary gas exchange and heart rate changes at start and end of exercise. Acta Physiol Scand 1974;415:1–68.
Linnarsson D, Karlsson J, Fagraeus L, Saltin B. Muscle metabolites and oxygen deficit with exercise in hypoxia. J Appl Physiol 1974;36:399–402.
Moore DP, Weston AR, Hughes JMB, Oakley CM, Cleland JGF. Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure. Lancet 1992;339:850–853.
Hickson RC, Bomze HA, Holloszy JO. Faster adjustment of O2 uptake to the energy requirement of exercise in the trained state. J Appl Physiol 1978;44:877–881.
Jones NL. Clinical Exercise Testing. Philadelphia: W.B. Saunders, 1988:208–212.
American Heart Association. Laboratory Standards for Exercise Testing. Dallas, 1994, in press.
Myers J, Walsh D, Sullivan M, Froelicher VF. Effect of sampling on variability and plateau in oxygen uptake. J Appl Physiol 1990;68:404–410.
Nelson RR, Glbel FL, Jorgensen CR, Wang K, Wang Y, Taylor HL. Hemodynamic predictors of myocardial oxygen consumption during static and dynamic exercise. Circulation 1974;50:1179–1189.
Hill DW, Cureton KJ, Collins MA, Grisham SC. Diurnal Variations in responses to exercise in “morning types” and “evening types.” J Sports Med 1988;28:213–219.
Handler CE, Sowton E. Diurnal variation and reproducibility of predischarge submaximal exercise testing after myocardial infarction. Br Heart J 1984;52:299–303.
Waters DD, McCans JL, Crean PA. Serial exercise testing in patients with effort angina: Variable tolerance, fixed threshold. J Am Coll Cardiol 1985;6:1011–1015.
Oram S, Sowton E. Tobacco angina. Q J Med 1963;32:115–143.
Aronow WS. Effect of passive smoking on angina pectoris. N Engl J Med 1978;299:21–24.
Deanfield J, Wright C, Krikler S, Ribeiro P, Fox K. Cigarette smoking and the treatment of angina with propranolol, atenolol, and nifedipine. N Engl J Med 1984;310:951–954.
Fox K, Jonathan A, Williams H, Selwyn A. Interaction between cigarettes and propranolol in treatment of angina pectoris. Br Med J 1980;3:191–193.
Heberden W. Some account of a disorder of the breast. Med Trans R Coll Physicians Lond 1972;2:59–67.
Cowley AJ, Fullwood CJ, Stainer K, Harrison E, Muller AF, Hampton JR. Post-prandial worsening of angina: All due to changes in cardiac output?
Goldstein RE, Redwood DR, Rosing DR, Beiser D, Epstein SE. Alterations in the circulatory response to exercise following a meal and their relationship to postprandial angina pectoris. Circulation 1971;44:90–100.
Dobmeyer DJ, Stine RA, Loler CV, Greenberg R, Schael SF. The arrhythmogenic effects of caffeine in human beings. N Engl J Med 1983;308:814–816.
Prineas FJ, Jacobs DR Jr, Crow RS, Blackburn H. Coffee, tea and VPB. J Chronic Dis 1980;33:67–72.
Whitsett TL, Shristensen HD, Hirsh DR. Cardiovascular effects of caffeine in humans. In: HH Wang, MR Blumenthal, SH Nagei, eds. Central Control Mechanisms and Related Topics. Mt. Kisco, NY: Futura Press, 1980:247–259.
Conrad KA, Blanchard J, Trand JM. Cardiovascular effects of caffeine in elderly men. J Am Geriatr Soc 1982;30:267–272.
Whitsett TL, Manion CV, Christensen D. Cardiovascular effects of coffee and caffeine. Am J Cardiol 1984;53:918–922.
Piters KM, Colombo A, Olson HG, Butman SM. Effect of coffee on exercise-induced angina pectoris due to coronary artery disease in habitual coffee drinkers. Am J Cardiol 1985;55:277–280.
Editor information
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Myers, J., Froelicher, V.F. (1994). Optimizing the Exercise Test for Pharmacological Studies in Patients with Angina Pectoris. In: Ardissino, D., Opie, L.H., Savonitto, S. (eds) Drug Evaluation in Angina Pectoris. Developments in Cardiovascular Medicine, vol 158. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2628-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2628-5_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6127-5
Online ISBN: 978-1-4615-2628-5
eBook Packages: Springer Book Archive